Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualize-se com a Progress in Mind Brazil	Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER